View Post

U.S. FDA Reaffirms Commitment to COVID-19 Vaccine Transparency

In COVID-19, Latest News by Precision Vaccinations

While Emergency Use Authorizations (EUA) have received increased attention during the COVID-19 public health emergency, they are not a new tool to the US Food and Drug Administration (FDA). 
The Commissioner of FDA Stephen M. Hahn M.D., took a moment on November 17, 2020, to reaffirm FDA’s commitment to transparency around the EUA process and share some updates on our plan to provide more information about FDA’s decisions to issue, revise or revoke EUAs for vaccines.

View Post

Cervical Cancer Prevention Investments Produce Significant ROI

In COVID-19, Latest News by Precision Vaccinations

The World Health Organization (WHO) Global Strategy to Accelerate the Elimination of Cervical Cancer announced today marks the first time that 194 countries commit to eliminating cancer – following the adoption of a resolution at the World Health Assembly in 2020.
Cervical cancer is a preventable disease that is also curable if detected early and adequately treated. Yet it is the 4th most common cancer among women globally. 
This WHO cervical cancer strategy outlines three key steps: vaccination, screening, and treatment.

View Post

Rochester’s Airport Launches Traveler Digital IDs

In Travel Vaccine News by Travel Vaccine

The Transportation Security Administration (TSA) checkpoint at Greater Rochester International Airport located in northern New York is now utilizing new state-of-the-art technology that confirms the validity of a traveler’s identification (ID) and their flight information in near real-time.
This innovative technology will enhance detection capabilities for identifying fraudulent documents at the security checkpoint.